Bo Andersson

965 total citations
30 papers, 791 citations indexed

About

Bo Andersson is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Bo Andersson has authored 30 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Pharmacology. Recurrent topics in Bo Andersson's work include Pharmacogenetics and Drug Metabolism (8 papers), Inflammatory mediators and NSAID effects (5 papers) and Alcohol Consumption and Health Effects (4 papers). Bo Andersson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Inflammatory mediators and NSAID effects (5 papers) and Alcohol Consumption and Health Effects (4 papers). Bo Andersson collaborates with scholars based in Sweden, United States and Canada. Bo Andersson's co-authors include Peter Moldéus, Dean P. Jones, Anver D. Rahimtula, Sten Orrenius, Margareta Berggren, Hjördis Thor, Staffan Eksborg, Roger Larsson, Robert G. Hahn and Magnus Nordenskjöld and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Bo Andersson

30 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Andersson Sweden 17 289 262 147 136 105 30 791
J G Kenna United Kingdom 19 605 2.1× 215 0.8× 158 1.1× 163 1.2× 66 0.6× 26 1.3k
T. Noguchi Japan 19 214 0.7× 486 1.9× 54 0.4× 99 0.7× 114 1.1× 40 1.2k
I. Bartošek Italy 17 163 0.6× 267 1.0× 70 0.5× 238 1.8× 59 0.6× 60 896
M M Galteau France 16 241 0.8× 372 1.4× 103 0.7× 131 1.0× 48 0.5× 43 1.1k
Mary Treinen Moslen United States 20 331 1.1× 363 1.4× 106 0.7× 161 1.2× 92 0.9× 59 1.1k
G J Mulder Netherlands 14 207 0.7× 248 0.9× 92 0.6× 227 1.7× 202 1.9× 29 723
Richard R. Erickson United States 14 206 0.7× 212 0.8× 59 0.4× 88 0.6× 71 0.7× 29 630
Ada Serroni United States 16 427 1.5× 711 2.7× 144 1.0× 207 1.5× 202 1.9× 23 1.6k
Egbert Scholtens Netherlands 23 287 1.0× 351 1.3× 186 1.3× 244 1.8× 121 1.2× 45 1.3k
Ronald M. Laethem United States 12 451 1.6× 258 1.0× 291 2.0× 171 1.3× 83 0.8× 18 817

Countries citing papers authored by Bo Andersson

Since Specialization
Citations

This map shows the geographic impact of Bo Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Andersson more than expected).

Fields of papers citing papers by Bo Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Andersson. The network helps show where Bo Andersson may publish in the future.

Co-authorship network of co-authors of Bo Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Andersson. A scholar is included among the top collaborators of Bo Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Andersson. Bo Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rajs, Jovan, et al.. (1997). Sudden Infant Death Syndrome: Postmortem Findings of Nicotine and Cotinine in Pericardial Fluid of Infants in Relation to Morphological Changes and Position at Death. Pediatric Pathology & Laboratory Medicine. 17(1). 83–97. 17 indexed citations
3.
Eksborg, Staffan, et al.. (1996). Doxorubicin- and daunorubicin-induced energy deprivation and nucleotide degradation in isolated cardiomyocytes. Toxicology. 114(1). 1–10. 19 indexed citations
4.
Andersson, Bo, et al.. (1996). Hydroperoxide-induced nucleotide degradation and adenosine formation in isolated rat cardiomyocytes. Toxicology. 106(1-3). 39–48. 14 indexed citations
5.
Andersson, Bo, et al.. (1995). Effect of irrigating fluids and prostate tissue extracts on isolated cardiomyocytes. Urology. 46(6). 821–824. 32 indexed citations
6.
Andersson, Bo, et al.. (1995). Effect of moderate ethanol intake on the heart: biochemical and morphological studies with isolated cardiomyocytes from rats fed a low-protein diet.. Journal of Studies on Alcohol. 56(2). 147–155. 6 indexed citations
7.
Sundwall, A., Bo Andersson, Michael Balls, et al.. (1994). Workshop: Immunotoxicology and in vitro possibilities. Toxicology in Vitro. 8(5). 1067–1074. 4 indexed citations
8.
Andersson, Bo, et al.. (1990). N-acetyl-p-benzoquinone imine-induced changes in the energy metabolism in hepatocytes. Chemico-Biological Interactions. 75(2). 201–211. 39 indexed citations
9.
Andersson, Bo & Dean P. Jones. (1985). Use of digitonin fractionation to determine mitochondrial transmembrane ion distribution in cells during anoxia. Analytical Biochemistry. 146(1). 164–172. 55 indexed citations
10.
Ross, David, Roger Larsson, Bo Andersson, et al.. (1985). The oxidation of p-phenetidine by horseradish peroxidase and prostaglandin synthase and the fate of glutathione during such oxidations. Biochemical Pharmacology. 34(3). 343–351. 44 indexed citations
11.
Nordenskjöld, Magnus, Bo Andersson, Anver D. Rahimtula, & Peter Moldéus. (1984). Prostaglandin synthase-catalyzed metabolic of some aromatic amines to genotoxic products. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 127(2). 107–112. 14 indexed citations
12.
Moldéus, Peter, Roger Larsson, David Ross, & Bo Andersson. (1984). Peroxidase-catalysed metabolism of drugs and carcinogens. Biochemical Society Transactions. 12(1). 20–23. 8 indexed citations
13.
Andersson, Bo, Magnus Nordenskjöld, Anver D. Rahimtula, & Peter Moldéus. (1982). Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products.. Molecular Pharmacology. 22(2). 479–485. 30 indexed citations
14.
Moldéus, Peter, et al.. (1979). REGULATION OF GLUCURONIDATION AND SULFATE CONJUGATION IN ISOLATED HEPATOCYTES. Drug Metabolism and Disposition. 7(6). 416–419. 43 indexed citations
15.
Andersson, Bo, Dean P. Jones, & S Orrenius. (1979). Effect of calcium ions on ethanol oxidation and drug glucuronidation in isolated hepatocytes. Biochemical Journal. 184(3). 709–711. 7 indexed citations
16.
Grafström, Roland, Peter Moldéus, Bo Andersson, & S Orrenius. (1979). Xenobiotic metabolism by isolated rat small intestinal cells.. PubMed. 57(5). 287–93. 20 indexed citations
17.
Andersson, Bo, Margareta Berggren, & Peter Moldéus. (1978). CONJUGATION OF VARIOUS DRUGS IN ISOLATED HEPATOCYTES. Drug Metabolism and Disposition. 6(6). 611–616. 48 indexed citations
18.
Jones, Dean P., Hjördis Thor, Bo Andersson, & Sten Orrenius. (1978). Detoxification reactions in isolated hepatocytes. Role of glutathione peroxidase, catalase, and formaldehyde dehydrogenase in reactions relating to N-demethylation by the cytochrome P-450 system.. Journal of Biological Chemistry. 253(17). 6031–6037. 129 indexed citations
19.
Andersson, Bo, et al.. (1978). Uptake of Glucuronides into Isolated Hepatocytes and their Effects on Glucuronide and Sulphate Conjugation. Acta Pharmacologica et Toxicologica. 43(4). 311–317. 5 indexed citations
20.
Moldéus, Peter, et al.. (1978). Interaction of ethanol oxidation with glucuronidation in isolated hepatocytes. Biochemical Pharmacology. 27(22). 2583–2588. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026